Keyword: Johnson & Johnson
News
23.08.2013
- Onyx Pharmaceuticals has given potential buyers, including Amgen, access to trial data on its new cancer drug, removing a key hurdle that was holding up deal talks, according to...
News
18.07.2013
- Chinese authorities investigating the alleged bribery of doctors and officials by GlaxoSmithKline have stopped the drugmaker's head of finance for China, a British citizen, from...
News
01.07.2013
- European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...
News
25.06.2013
- The Lion City - The Merlion - a mythical creature with the head of a lion and the body of a fish - is regarded as the Singapore icon ("Singapura" means "lion city" in Sanskrit). As...
News
20.06.2013
- European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant to...
News
18.06.2013
- Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired...
News
06.06.2013
- Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. The Mediterranean country already boasts the world's...
News
03.06.2013
- A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said...
